| Literature DB >> 34622126 |
Jørgen Guldberg-Møller1,2, Marius Henriksen1, Karen Ellegaard1, Merete Haedersdal3, Luna T Lazar3, Lars Erik Kristensen1, Mette Mogensen3.
Abstract
OBJECTIVES: Nailfold video capillaroscopy (NVC) and angiographic optical coherence tomography (OCTA) have potential in diagnosing PsA and differentiating it from psoriasis vulgaris (PsO) and hand OA. We aimed to assess the diagnostic properties of NVC and OCTA in patients with PsA compared with patients with PsO and hand OA based on nailfold capillary patterns.Entities:
Keywords: nailfold capillaroscopy; optical coherence tomography; osteoarthritis; psoriasis; psoriatic arthritis
Year: 2021 PMID: 34622126 PMCID: PMC8493103 DOI: 10.1093/rap/rkab065
Source DB: PubMed Journal: Rheumatol Adv Pract ISSN: 2514-1775
1Flowchart of study participants
1Reasons for declining further participation: no response after first examination day (PsA n = 1 and PsO = 1). 2Flow information not required owing to deformity (PsA n = 5 and OA n = 1). 3Software breakdowns (PsA n = 1). 4Nailbed hyperkeratosis (PsA n = 4, PsO n = 2 and OA n = 1). NVC: nailfold video capillaroscopy; OCTA: angiographic optical coherence tomography; PsO: skin psoriasis. Flow chart template modified from http://www.equator-network.org/reporting-guidelines/stard/
Demographics and characteristics of PsA, PsO and OA patients
| Descriptives | PsA ( | PsO ( | Hand OA ( |
|---|---|---|---|
| Sociodemography/treatment | |||
| Females, | 21 (42) | 5 (41) | 13 (100) |
| Age, mean ( | 54.4 (12.0) | 55.3 (18.0) | 69.5 (8.9) |
| Disease duration, months | 60 [19; 120] | 25 [12; 96] | 78 [12; 99] |
| Height, mean ( | 172.8 (10.0) | 173.3 (10.0) | 160.2 (6.7) |
| weight, mean ( | 85.7 (16.8) | 82.6 (16.3) | 62.7 (10.7) |
| BMI, mean ( | 28.8 (6.6) | 27.5 (5.3) | 24.3 (2.5) |
| PASI (if BSA >1) (0–72) | 1.9 [0.8; 4.0] | 1.8 [0.0; 6.1] | 0.0 [0.0; 0.0] |
| Treated with csDMARDs, | 30 (60) | 3 (25) | 1 (7) |
| Treated with bDMARDs, | 4 (8) | 5 (42) | 0 |
| Treated with both bDMARDs and csDMARDs, | 7 (14) | 0 | 0 |
| No treatment, | 9 (18) | 4 (33) | 12 (93) |
| Nail characteristics | |||
| NAPSI total score finger 2 (0–8) | 3.0 [2.0; 4.0] | 3.5 [2.0; 5.0] | 0.0 [0.0; 0.0] |
| NAPSI total score finger 3 (0–8) | 3.0 [2.0; 4.0] | 4.0 [2.3; 4.8] | 0.0 [0.0; 0.0] |
| NAPSI total score finger 4 (0–8) | 2.0 [1.0; 4.0] | 3.5 [2.0; 5.8] | 0.0 [0.0; 0.0] |
| NAPSI total score finger 5 (0–8) | 2.0 [1.0; 4.0] | 2.0 [1.0; 3.0] | 0.0 [0.0; 0.0] |
| Nail pitting, | 83/200 (42) | 8/48 (17) | 0/52 (0) |
| Nail leuconychia, | 9/200 (5) | 3/48 (6) | 2/52 (4) |
| Nail crumbling, | 17/200 (9) | 12/48 (25) | 0/52 (0) |
| Nail lunula red spots, | 5/200 (3) | 0/48 (0) | 0/52 (0) |
| Nail onychorrhexis, | 17/200 (9) | 6/48 (13) | 3/52 (6) |
| Nail oil spot change, | 29/200 (15) | 11/48 (23) | 0/52 (0) |
| Nail onycholysis, | 109/200 (55) | 23/48 (48) | 0/52 (0) |
| Nail subungual hyperkeratosis, | 7/200 (4) | 4/48 (8) | 0/52 (0) |
| Nail splinter haemorrhage, | 17/200 (9) | 5/48 (10) | 1/52 (2) |
Data are presented as median [25th–75th percentiles] unless otherwise stated. bDMARDs: biological DMARDs; csDMARDs: conventional DMARDs; NAPSI: nail psoriasis severity index; PASI: Psoriasis Area Severity Index; BSA: Body surface area; PsO: psoriasis vulgaris.
The distribution of nailfold video capillaroscopy and angiographic optical coherence tomography capillary morphology between PsA, PsO and OA
| NVC rating | PsA ( | PsO ( | OA ( | PsA | PsA |
|---|---|---|---|---|---|
| NVC | |||||
| Below mean capillary density, | 95 (51) | 14 (31) | 24 (51) | 0.019 | 1.000 |
| Capillary disorganization, | 84 (45) | 24 (57) | 23 (48) | 0.172 | 0.746 |
| OCTA rating | PsA ( | PsO ( | OA ( | PsA | PsA |
| Capillary morphology | PsA ( | PsO ( | OA ( | PsA | PsA |
| Irregularly enlarged capillaries, | 42 (22) | 14 (33) | 12 (25) | 0.163 | 0.703 |
| Giant capillary, | 3 (2) | 0 | 0 | 0.631 | 0.610 |
| Microhaemorrhages, | 24 (13) | 3 (7) | 1 (2) | 0.429 |
|
| Capillary ramifications, | 27 (14) | 10 (24) | 14 (29) | 0.162 |
|
| OCTA | |||||
| Below mean capillary density, | 103 (53) | 10 (21) | 17 (33) |
|
|
| Irregularly enlarged capillaries, | 66 (34) | 27 (56) | 10 (19) |
| 0.062 |
| Giant capillary, | 0 | 0 | 0 | – | – |
| Microhaemorrhages, | 0 | 0 | 0 | – | – |
| Capillary ramifications, | 0 | 0 | 0 | – | – |
| Capillary disorganization, | 108 (55) | 22 (46) | 25 (49) | 0.263 | 0.529 |
| OCT | |||||
| Nail thickness | 0.62 (0.13) | 0.73 (0.39) | 0.59 (0.08) | 0.876 |
|
| OCTA blood flow percentage, mean ( | 6.00 (2.94) | 6.94 (3.08) | 7.88 (3.30) | 0.052 |
|
| Qualitative evaluation of NVC morphology | |||||
| Tortuous/crossed capillaries, | 105 (55) | 34 (71) | 29 (56) |
| 1.000 |
| Enlarged capillary diameter, | 33 (17) | 10 (21) | 9 (17) | 0.674 | 1.000 |
| Ramified capillaries, | 24 (13) | 7 (15) | 10 (19) | 0.810 | 0.258 |
| Microhaemorrhages, | 32 (17) | 3 (6) | 4 (8) | 0.106 | 0.125 |
| Elongated capillaries, | 11 (6) | 2 (4) | 2 (4) | 0.747 | 0.741 |
| Different capillary shapes, glomerular, | 5 (3) | 6 (13) | 1 (2) |
| 1.000 |
Data are presented as a percentage of capillary finding within the group unless otherwise stated. Differences between PsA and the other groups are presented as a two-sided P-value; values of P < 0.05 are considered significant. aOne patient from the PsO group was excluded from this analysis because a nail thickness of >2.0 mm exceeded the maximum penetration depth of the OCT laser, thus representing an outlier. NVC: nailfold video capillaroscopy; OA: hand OA; OCTA: angiographic optical coherence tomography; PsO: psoriasis vulgaris.
2Qualitative nailfold video capillaroscopy morphology in patients with PsA, psoriasis vulgaris and hand OA
(A) Ramified capillaries (white ring) in PsA. (B) Elongated capillaries in PsA. (C) Elongated capillaries with microhaemorrhages (white arrow) in PsA. (D) Microhaemorrhages (white arrows) in PsA. (E) Glomerular and dilated capillaries in OA (white ring). (F) Glomerular and dilated capillaries in psoriasis vulgaris (white rings). (G) Crossed/tortuous capillaries in PsA. (H) Capillary ramifications in OA (white ring). Dilated capillaries are defined to have a diameter of 20–50 µm.
3Optical coherence tomography of the nail and nailbed in PsA, psoriasis vulgaris, and OA
*: nail plate; ¤: cuticle; white arrow: proximal nailfold; §: 1 mm field.
The odds ratio for having PsA diagnosis according to capillary morphology and blood flow
| Capillary parameter | Groups | Odds ratio (95% CI) | |
|---|---|---|---|
| NVC microhaemorrhages | PsA | 1.54 (0.17, 13.92) | 0.701 |
| PsA | 0.27 (0.01, 6.72) | 0.424 | |
| PsA | 2.12 (0.27, 16.72) | 0.473 | |
| NVC glomerular | PsA | 0.33 (0.02, 5.84) | 0.447 |
| PsA | 0.81 (0.11, 61.71) | 0.923 | |
| PsA | 0.49 (0.03, 7.68) | 0.611 | |
| NVC crossed capillaries | PsA | 0.61 (0.15, 2.45) | 0.480 |
| PsA | 1.04 (0.26, 4.18) | 0.960 | |
| PsA | 0.77 (0.24, 2.46) | 0.652 | |
| OCTA below mean capillary density | PsA | 2.92 (0.68, 12.50) | 0.148 |
| PsA | 0.51 (0.27, 2.06) | 0.343 | |
| PsA | 2.41 (0.73, 7.88) | 0.147 | |
| OCTA Irregularly enlarged | PsA | 0.50 (0.13, 1.96) | 0.318 |
| PsA | 0.56 (0.11, 2.71) | 0.465 | |
| PsA | 0.89 (0.27, 2.97) | 0.849 | |
| OCTA blood flow percentage | PsA | 0.92 (0.72, 1.17) | 0.494 |
| PsA | 0.19 (0.93, 1.46) | 0.186 | |
| PsA | 0.88 (0.71, 1.08) | 0.219 |
Values are presented as the odds ratio and corresponding 95% CI of capillary haemorrhages, glomerular or crossed capillaries in NVC and below mean capillary density and irregularly enlarged capillaries in OCTA or blood flow percentage compared with PsO, OA or PsO and OA grouped. NVC: nailfold video capillaroscopy; OA: hand OA; OCTA: angiographic optical coherence tomography; PsO: psoriasis vulgaris.